Characterization of antihistamines using biphasic cutaneous reaction in BALB/c mice

Life Sciences

Volumn 63, Issue 11, 1998, Pages A145-A150

  Inagaki, Naoki ^a   Sakurai, Toshimi ^a   Toru, Abe ^a   Musoh, Keiichi ^a   Kawasaki, Hirokazu ^a   Tsunematsu, Masako ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Biphasic cutaneous reaction; Emedastine; Histamine H1 receptor antagonist; Immunoglobulin E; Late phase reaction; Mequitazine; Oxatomide

Indexed keywords

AZELASTINE; CETIRIZINE; CHLORCYCLIZINE; CHLORPHENIRAMINE MALEATE; CYPROHEPTADINE; DIPHENHYDRAMINE; EMEDASTINE; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN; MEQUITAZINE; OXATOMIDE; TERFENADINE;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; EDEMA; FEMALE; INFLAMMATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; SKIN DEFECT;

EID: 0032493751     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00356-7     Document Type: Article

References (20)

1. 1. E.F. SIMONS and K.J. SIMONS, N.Engl.J.Med. 330, 1663-1669 (1994).
2. 2. L.M. DU BUSKE, J.Allergy Clin.Immunol. 98 S307-S318 (1996).
3. 3. F.M. GENGO, J.Allergy Clin.Immunol. 98 S319-S325 (1996).
4. 4. R.G. TOWNLEY, J.Allergy Clin.Immunol. 90 720-725 (1992).
5. 5. A.J. CHAUHAN and S.T. HOLGATE, Immunopharmacology of Allergic Diseases, R.G. Townley and D.K. Agrawal (Eds), 605-638, Marcel Dekker, New York (1996).
6. 6. M.C. RAY, M.D. THARP, T.J. SULLIVAN and R.E. TIGELAAR, J.Immunol. 131 , 1096-1102 (1983).
7. 7. I. KATAYAMA, R. TANEI H. YOKOZEKI, K. NISHIOKA and Y. DOHI Int.Arch.Allergy Appl.Immunol. 93 148-154 (1990).
8. 8. H. NAGAI, T. SAKURAI, N. INAGAKI and H. MORI, Biol.Pharm.Bull. 18 239-245 (1995).
9. 9. H. NAGAI, T. SAKURAI, T. ABE, A. MATSUO, K. MUSOH, M. TSUNEMATSU and N. INAGAKI, Inflamm.Res. 45 136-140 (1996).
10. 10. N. INAGAKI, M. TSUNEMATSU, T. SAKURAI, A. MATSUO and H. NAGAI, Gen.Pharmacol. 28 93-97 (1997).
11. 11. K. MUSOH, N. NAKAMURA, Y. UEDA, N. INAGAKI and H. NAGAI, Int.Arch.Allergy Immunol. 115 91-96 (1998).
12. 12. A.B. KAY , S. YING, V. VARNEY, M. GAGA, S.R. DURHAM, R. MOQBEL, A.J. WARDLOW and Q. HAMID, J.Exp.Med. 173 775-778 (1991).
13. 13. J. DOLOVICH, F.E. HARGREAVE, M. JORDANA and J. DENBURG, J.Allergy Clin.Immunol. 83 521-524 (1989).
14. 14. Z. PELICAN and M. PELICAN-FILIPEK, J.Allergy Clin.Immunol. 83 1068-1079 (1989).
15. 15. S. BONINI, S. BONINI, M.G. BUCCI, A. BERRUTO, E. ADRIANI, F. BALSANO and M.R. ALLANSMITH, J.Allergy Clin.Immunol. 86 869-876 (1990).
16. 16. K. TANIGUCHI, Y. MASUDA and K. TAKANAKA, Japan.J.Pharmacol. 52 101-108 (1990).
17. 17. S. UMEKI, Japan.J. Allergol. 40 1511-1520 (1991).
18. 18. N. FUKUISHI, T. KAN, K. HIROSE, R. AKAGI and M. AKAGI, Japan.J.Pharmacol. 68 449-452 (1995).
19. 19. N. MATSUDA, T. SAITO and A. YAMASHITA, Japan.Pharmacol.Ther. 21 1475-1478 (1993).
20. 20. A.E. EL SHAZLY, K. MASUYAMA, Y. SAMEJIMA, M. EURA and T. ISHIKAWA, Immunopharmacol. Immunotoxicol. 18 587-595 (1996).